Literature DB >> 21315446

Osteoconductive properties of poly(96L/4D-lactide)/beta-tricalcium phosphate in long term animal model.

Guy Daculsi1, Eric Goyenvalle, Ronan Cognet, Eric Aguado, Esa O Suokas.   

Abstract

The objective of this study was to determine the effect of calcium phosphate mineral content on the bone in-growth at the expense of composite of co-polylactide polymer charged with 2 different ratios of β-TCP granules (10 and 24 w-% of β-TCP). The evaluation was realized in a long term rabbit bone model. After 24, 48 and 76 weeks, the implants were examined by micro CT, scanning electron microscopy (SEM) using backscattered electron (BSE) and light microscopy (polarized and blue light microscopy). No foreign body reaction was detected during the 76 weeks follow-up in any of the test samples. Polymer hydrolysis began at approximately 24 weeks, by 76 weeks, the pure polymer implant had begun to release P(96L/4D)LA particles and show signs of peripheral localized bone resorption. A decrease in the amount of CaP was noticed between 24 and 76 weeks in both 10 wt-% and 24 wt-% β-TCP/P(96L/4D)LA composites. The study showed that the highest bone in-growth was with 24 wt-% β-TCP/P(96L/4D)LA composite. Bone in-growth and mineralization were evident for the composites associated with specific peripheral bone architecture. Fluorescent labelling demonstrated high bone in-growth and remodeling at the interface, while for pure co-polymer no bone remodeling or bone activity was maintained after 48 weeks. The study demonstrated the positive effect of calcium phosphate content into P(96L/4D)LA. This kind of composite is a suitable resorbable osteoconductive matrix, which provides long term stability required for ligament fixation device.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21315446     DOI: 10.1016/j.biomaterials.2011.01.033

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  10 in total

1.  [Biodegradable screw versus a press-fit bone plug fixation for ACL reconstruction: a prospective randomized study].

Authors:  B Geiges; C von Falck; K Knobloch; C Haasper; R Meller; C Krettek; S Hankemeier; J Brand; M Jagodzinski
Journal:  Unfallchirurg       Date:  2013-02       Impact factor: 1.000

2.  Analysis of the factors affecting the inherent viscosity of oriented polylactides during hydrolytic degradation.

Authors:  Mikko Huttunen
Journal:  J Mater Sci Mater Med       Date:  2013-03-08       Impact factor: 3.896

3.  Structure and properties of PLLA/β-TCP nanocomposite scaffolds for bone tissue engineering.

Authors:  Tao Lou; Xuejun Wang; Guojun Song; Zheng Gu; Zhen Yang
Journal:  J Mater Sci Mater Med       Date:  2015-01-13       Impact factor: 3.896

4.  Strength retention behavior of oriented PLLA, 96L/4D PLA, and 80L/20D,L PLA.

Authors:  Mikko Huttunen; Minna Kellomäki
Journal:  Biomatter       Date:  2013-09-11

5.  Ceramic identity contributes to mechanical properties and osteoblast behavior on macroporous composite scaffolds.

Authors:  Diana G Morales-Hernandez; Damian C Genetos; David M Working; Kaitlin C Murphy; J Kent Leach
Journal:  J Funct Biomater       Date:  2012-05-23

6.  Local delivery of a selective androgen receptor modulator failed as an anabolic agent in a rat bone marrow ablation model.

Authors:  Hannu T Aro; Julia Kulkova; Niko Moritz; Esa Kähkönen; Riina H Mattila
Journal:  Acta Orthop       Date:  2015-07-22       Impact factor: 3.717

7.  Polylactide Composite Pins Reinforced with Bioresorbable Continuous Glass Fibers Demonstrating Bone-like Apatite Formation and Spiral Delamination Degradation.

Authors:  Xiao-Yan Cao; Na Tian; Xiang Dong; Cheng-Kung Cheng
Journal:  Polymers (Basel)       Date:  2019-05-06       Impact factor: 4.329

8.  A Polymer for Application as a Matrix Phase in a Concept of In Situ Curable Bioresorbable Bioactive Load-Bearing Continuous Fiber Reinforced Composite Fracture Fixation Plates.

Authors:  Artem Plyusnin; Jingwei He; Cindy Elschner; Miho Nakamura; Julia Kulkova; Axel Spickenheuer; Christina Scheffler; Lippo V J Lassila; Niko Moritz
Journal:  Molecules       Date:  2021-02-26       Impact factor: 4.411

9.  Processing and sustained in vitro release of rifampicin containing composites to enhance the treatment of osteomyelitis.

Authors:  Niina Ahola; Minna Veiranto; Noora Männistö; Matti Karp; Jaana Rich; Alexander Efimov; Jukka Seppälä; Minna Kellomäki
Journal:  Biomatter       Date:  2012 Oct-Dec

10.  An in vitro study of composites of poly(L-lactide-co-ε-caprolactone), β-tricalcium phosphate and ciprofloxacin intended for local treatment of osteomyelitis.

Authors:  Niina Ahola; Noora Männistö; Minna Veiranto; Matti Karp; Jaana Rich; Alexander Efimov; Jukka Seppälä; Minna Kellomäki
Journal:  Biomatter       Date:  2013-01-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.